General Information
Revision date
2012-11-16
Product name
Prevnar 13
Product Synonyms
Pneumococcal 13-Valent Conjugate Vaccine
Chemical name
Not determined
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
Section 2
SECTION 2: Hazards identification
Directive 67/548/EEC: Appearance: White homogenous suspension
Hazard statements
Non-hazardous in accordance with international standards for workplace safety.
Additional information
Short Term: In the event of accidental injection, an allergic reaction may occur. If an allergic reaction occurs, the worker should be removed to the nearest emergency room and the appropriate therapy instituted. Known Clinical Effects: Based on clinical trials in humans, possible adverse effects following exposure to this compound may include: swelling, tenderness, and redness at the injection site, fever, lack of appetite, irritability, sleepiness (somnolence), sleeplessness, allergic reaction, and anaphylactic reactions. Australian Hazard Classification Non-Hazardous Substance. Non-Dangerous Goods. (NOHSC): Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008. This substance is not classified as dangerous according to Directive 67/548/EEC. Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
